Correction to AstraZeneca's Lesinurad Gout Story
23 January 2015 - 4:51AM
Dow Jones News
European Medicines Agency accepts AstraZeneca's marketing
application for Lesinurad, a treatment for gout. "AstraZeneca's
Lesinurad Gout Treatment Receives EMA Approval," at 0715 GMT,
misstated in the first paragraph that the European Medicines Agency
has approved rather than accepted its marketing application for
Lesinurad. The second paragraph should also begin with "If
approved" not "The authorization means".
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Apr 2024 to May 2024
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From May 2023 to May 2024